These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 23418340)

  • 21. Comparison with first round findings of faecal haemoglobin concentrations and clinical outcomes in the second round of a biennial faecal immunochemical test based colorectal cancer screening programme.
    Clark GR; Fraser CG; Strachan JA; Steele RJ
    J Med Screen; 2022 Dec; 29(4):249-254. PubMed ID: 35747907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Service evaluation of faecal immunochemical testing and anaemia for risk stratification in the 2-week-wait pathway for colorectal cancer.
    Chapman C; Bunce J; Oliver S; Ng O; Tangri A; Rogers R; Logan RF; Humes DJ; Banerjea A
    BJS Open; 2019 Jun; 3(3):395-402. PubMed ID: 31183456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance of two faecal immunochemical tests for the detection of advanced neoplasia at different positivity thresholds: a cross-sectional study of the Dutch national colorectal cancer screening programme.
    de Klerk CM; Wieten E; Lansdorp-Vogelaar I; Bossuyt PM; Spaander MC; Dekker E
    Lancet Gastroenterol Hepatol; 2019 Feb; 4(2):111-118. PubMed ID: 30497962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Appraisal of the faecal haemoglobin, age and sex test (FAST) score in assessment of patients with lower bowel symptoms: an observational study.
    Digby J; Strachan JA; Mowat C; Steele RJC; Fraser CG
    BMC Gastroenterol; 2019 Dec; 19(1):213. PubMed ID: 31829141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of the faecal immunochemical test at a range of positivity thresholds compared with the guaiac faecal occult blood test in the NHS Bowel Cancer Screening Programme in England.
    Murphy J; Halloran S; Gray A
    BMJ Open; 2017 Oct; 7(10):e017186. PubMed ID: 29079605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Faecal haemoglobin distributions by sex, age, deprivation and geographical region: consequences for colorectal cancer screening strategies.
    Clark GRC; Strachan JA; McPherson A; Digby J; Mowat C; Steele RJC; Fraser CG
    Clin Chem Lab Med; 2020 Nov; 58(12):2073-2080. PubMed ID: 32324157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Faecal haemoglobin concentrations in women and men diagnosed with colorectal cancer in a national screening programme.
    Clark GR; Digby J; Fraser CG; Strachan JA; Steele RJ
    J Med Screen; 2022 Mar; 29(1):26-31. PubMed ID: 34806935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Faecal immunochemical testing and blood tests for prioritization of urgent colorectal cancer referrals in symptomatic patients: a 2-year evaluation.
    Bailey JA; Weller J; Chapman CJ; Ford A; Hardy K; Oliver S; Morling JR; Simpson JA; Humes DJ; Banerjea A
    BJS Open; 2021 Mar; 5(2):. PubMed ID: 33693553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Automated immunochemical quantitation of haemoglobin in faeces collected on cards for screening for colorectal cancer.
    Fraser CG; Mathew CM; McKay K; Carey FA; Steele RJ
    Gut; 2008 Sep; 57(9):1256-60. PubMed ID: 18467371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. One or two faecal immunochemical tests in an organised population-based colorectal cancer screening programme in Murcia (Spain).
    Tourne-Garcia C; Perez-Riquelme F; Monteagudo-Piqueras O; Fraser CG; Yepes-Garcia P
    J Med Screen; 2022 Dec; 29(4):231-240. PubMed ID: 35578555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Faecal haemoglobin concentrations are associated with all-cause mortality and cause of death in colorectal cancer screening.
    Kaalby L; Deding U; Al-Najami I; Berg-Beckhoff G; Bjørsum-Meyer T; Laurberg T; Shaukat A; Steele RJC; Koulaouzidis A; Rasmussen M; Kobaek-Larsen M; Baatrup G
    BMC Med; 2023 Jan; 21(1):29. PubMed ID: 36691009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of Increasing Screening Age and Fecal Hemoglobin Cutoff Concentrations in a Colorectal Cancer Screening Program.
    Wieten E; Schreuders EH; Nieuwenburg SA; Hansen BE; Lansdorp-Vogelaar I; Kuipers EJ; Bruno MJ; Spaander MC
    Clin Gastroenterol Hepatol; 2016 Dec; 14(12):1771-1777. PubMed ID: 27567693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased uptake and improved outcomes of bowel cancer screening with a faecal immunochemical test: results from a pilot study within the national screening programme in England.
    Moss S; Mathews C; Day TJ; Smith S; Seaman HE; Snowball J; Halloran SP
    Gut; 2017 Sep; 66(9):1631-1644. PubMed ID: 27267903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Faecal haemoglobin concentration influences risk prediction of interval cancers resulting from inadequate colonoscopy quality: analysis of the Taiwanese Nationwide Colorectal Cancer Screening Program.
    Chiu SY; Chuang SL; Chen SL; Yen AM; Fann JC; Chang DC; Lee YC; Wu MS; Chou CK; Hsu WF; Chiou ST; Chiu HM
    Gut; 2017 Feb; 66(2):293-300. PubMed ID: 26515543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fecal hemoglobin concentration as a measure of risk to tailor colorectal cancer screening: are we there yet?
    Garcia M; Milà N; Binefa G; Benito L; Gonzalo N; Moreno V
    Eur J Cancer Prev; 2015 Jul; 24(4):321-7. PubMed ID: 25370684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Faecal immunochemical tests (FIT) in the assessment of patients presenting with lower bowel symptoms: Concepts and challenges.
    Fraser CG
    Surgeon; 2018 Oct; 16(5):302-308. PubMed ID: 29548552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of a higher fecal immunochemistry test cut-off on pathology detected in subsequent rounds of a colorectal screening program.
    Gibson DJ; Mooney T; Mooney J; Mulcahy HE; O'Donoghue D
    Gastrointest Endosc; 2019 Mar; 89(3):518-522. PubMed ID: 30142350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Yield of colorectal cancer at colonoscopy according to faecal haemoglobin concentration in symptomatic patients referred from primary care.
    McSorley ST; Digby J; Clyde D; Cruickshank N; Burton P; Barker L; Strachan JA; Fraser CG; Smith K; Mowat C; Winter J; Steele RJC
    Colorectal Dis; 2021 Jul; 23(7):1615-1621. PubMed ID: 33064898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can quantification of faecal occult blood predetermine the need for colonoscopy in patients at risk for non-syndromic familial colorectal cancer?
    Levi Z; Rozen P; Hazazi R; Vilkin A; Waked A; Maoz E; Birkenfeld S; Niv Y
    Aliment Pharmacol Ther; 2006 Nov; 24(10):1475-81. PubMed ID: 17032281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know.
    Tinmouth J; Lansdorp-Vogelaar I; Allison JE
    Gut; 2015 Aug; 64(8):1327-37. PubMed ID: 26041750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.